Efficacy and safety of combination therapy with interferon plus ribavirin in HIV-infected patients with chronic hepatitis C.

被引:0
|
作者
Pérez-Olmeda, M
Romero, M
Asensi, V
Sanchez-Montero, R
Ochoa, A
García-Samaniego, J
Soriano, V
机构
[1] Inst Salud Carlos III, Hosp Carlos III, Madrid, Spain
[2] Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Spain
[3] Complejo Hosp Caceres, Caceres, Spain
[4] Hosp Mutua Tarrasa, Barcelona, Spain
[5] Inst Salud Carlos III, Madrid, Spain
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
641
引用
收藏
页码:332A / 332A
页数:1
相关论文
共 50 条
  • [31] Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine
    Rudolf E Stauber
    Harald Hofer
    Franz Hackl
    Kurt Schüze
    Christian Datz
    Karin Hegenbarth
    Wolfgang Jessner
    Petra Steindl-Munda
    Peter Ferenci
    Wiener Klinische Wochenschrift, 2004, 116 : 530 - 535
  • [32] Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine
    Stauber, RE
    Hofer, H
    Hackl, F
    Schütze, K
    Datz, C
    Hegenbarth, K
    Jessner, W
    Steindl-Munda, P
    Ferenci, P
    WIENER KLINISCHE WOCHENSCHRIFT, 2004, 116 (15-16) : 530 - 535
  • [33] Pegylated interferon α2a plus ribavirin versus pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Berenguer, J.
    Gonzalez-Garcia, J.
    Lopez-Aldeguer, J.
    Von-Wichmann, M. A.
    Quereda, C.
    Hernando, A.
    Sanz, J.
    Tural, C.
    Ortega, E.
    Mallolas, J.
    Santos, I.
    Miralles, P.
    Montes, M. L.
    Bellon, J. M.
    Esteban, H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1256 - 1263
  • [34] EFFICACY AND SAFETY OF ALPHA-INTERFERON TREATMENT FOR CHRONIC HEPATITIS-C IN HIV-INFECTED PATIENTS
    SORIANO, V
    GARCIASAMANIEGO, J
    BRAVO, R
    CASTRO, A
    ODRIOZOLA, PM
    GONZALEZ, J
    COLMENERO, M
    CARBALLO, E
    SUAREZ, D
    LLIBRE, JM
    ALBERDI, JC
    PEDREIRA, J
    GONZALEZLAHOZ, J
    LOPEZCALVO, S
    GONZALEZANGLADA, I
    VAZQUEZ, J
    DELROMERO, J
    RODRIGUEZ, C
    GARCIA, S
    MORENO, A
    FERNANDEZCRUZ, E
    ZABAY, JM
    COSIN, J
    TOR, J
    MUGA, R
    BARRIO, E
    MARTINEZVAZQUEZ, J
    SANTAMARIA, JM
    RODRIGUEZPINERO, J
    MUNOZ, F
    JOURNAL OF INFECTION, 1995, 31 (01) : 9 - 13
  • [35] Combination of interferon (IFN) induction therapy and ribavirin in chronic hepatitis C.
    Ferenci, P
    Brunner, H
    Vogel, W
    Gschwantler, M
    Datz, C
    Hackl, F
    Steindl-Munda, PE
    Hofer, H
    Mueller, C
    Mueller, C
    GASTROENTEROLOGY, 2000, 118 (04) : A961 - A961
  • [36] Combination therapy with daily interferon alpha and ribavirin in naive patients with chronic hepatitis C.
    Rothstein, KD
    Suvannasankha, A
    Digreggorio, K
    Gross, F
    Peikin, S
    Mushnick, A
    Deangelo, C
    Salowe, D
    Siegel, H
    Shaw, E
    Bond, K
    Manzarbeitia, C
    HEPATOLOGY, 1999, 30 (04) : 619A - 619A
  • [37] Activity of combination therapy with interferon alfa-2b plus ribavirin in chronic hepatitis C patients co-infected with HIV
    Dieterich, DT
    Purow, JM
    Rajapaksa, R
    SEMINARS IN LIVER DISEASE, 1999, 19 : 87 - 94
  • [38] Oxidative stress and IFN plus ribavirin combination therapy in patients with chronic hepatitis C.
    Morisco, F
    Verde, V
    Fogliano, V
    Ritieni, A
    Iasevoli, P
    Tuccillo, C
    De Luise, G
    Caporaso, N
    GASTROENTEROLOGY, 2000, 118 (04) : A1471 - A1471
  • [39] Interferon plus ribavirin for chronic hepatitis C HIV+ patients
    Soriano, V
    González, J
    Pérez-Olmeda, M
    García-Samaniego, J
    AIDS, 1998, 12 : S92 - S92
  • [40] Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C
    Hu, C. -C.
    Lin, C. -L.
    Kuo, Y. -L.
    Chien, C. -H.
    Chen, S. -W.
    Yen, C. -L.
    Lin, C. -Y.
    Chien, R. -N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 81 - 90